Membrane-type 1 matrix metalloproteinase mRNA expression in colorectal cancer
- 1 March 2000
- journal article
- Published by Wolters Kluwer Health in Diseases of the Colon & Rectum
- Vol. 43 (3) , 389-395
- https://doi.org/10.1007/bf02258307
Abstract
Membrane-type matrix metalloproteinases are recently described proteolytic enzymes belonging to the matrix metalloproteinase family. Initial studies have indicated that membrane-type matrix metalloproteinases are involved in tumor invasion and metastasis. Membrane-type 1 matrix metalloproteinase is the first membrane-type matrix metalloproteinase to be described. The aim of this study was to investigate the expression of membrane-type 1 matrix metalloproteinase mRNA in colorectal cancer. Samples were collected from surgical specimens of patients with colorectal adenocarcinoma and were immediately frozen in liquid nitrogen and stored at −80°C until processed. Both normal and cancer tissue was taken from each patient. TNM stage, tumor differentiation, mucin production, and vascular invasion were assessed. Northern blotting was used to quantify membrane-type 1 matrix metalloproteinase mRNA levels in the samples using a membrane-type 1 matrix metalloproteinase cDNA clone. X-ray film images were digitized and densitometry was used to quantify bands. All samples were normalized against 18S rRNA levels. Results are expressed as the ratio of cancer to normal tissue levels. Statistical analysis was performed using analysis of variance, with P<0.05 accepted as the level of significance. A total of 32 samples were prospectively analyzed. The correlation between TNM stage and increased expression of membrane-type 1 matrix metalloproteinase mRNA in cancer tissue over normal tissue is expressed in the mean ratio of cancer to normal tissue expression for Stages I through IV, respectively: 1.4 ± 0.2 (12 patients); 4.1 ± 2.6 (8 patients); 3.4 ± 3 (7 patients); and 4.5 ± 5 (5 patients). Stage I is significantly different from Stages II and IV ( P<0.05). These preliminary results show an overall increasing trend in membrane-type 1 matrix metalloproteinase expression with increasing tumor stage. However, there was no correlation between membrane-type 1 matrix metalloproteinase expression and mucin production, degree of tumor differentiation, or vascular invasion. Preliminary results indicate that membrane-type 1 matrix metalloproteinase levels correlate with increasing tumor stage.Keywords
This publication has 32 references indexed in Scilit:
- Production of Membrane-type Matrix Metalloproteinase-1 (MT-MMP-1) in Early Human Placenta: A Possible Role in Placental Implantation?Journal of Histochemistry & Cytochemistry, 1998
- Membrane‐Type Matrix Metalloproteinases 1 and 2 Exhibit Broad‐Spectrum Proteolytic Capacities Comparable to Many Matrix MetalloproteinasesEuropean Journal of Biochemistry, 1997
- Transmembrane/cytoplasmic domain-mediated membrane type 1-matrix metalloprotease docking to invadopodia is required for cell invasionProceedings of the National Academy of Sciences, 1997
- Membrane Type 1 Matrix Metalloproteinase Digests Interstitial Collagens and Other Extracellular Matrix MacromoleculesJournal of Biological Chemistry, 1997
- Cellular Mechanisms for Human Procollagenase-3 (MMP-13) ActivationJournal of Biological Chemistry, 1996
- Membrane-type matrix metal ioproteinase-1 expression at the site ofhuman placentationPlacenta, 1996
- Intermolecular Autolytic Cleavage Can Contribute to the Activation of Progelatinase A by Cell MembranesJournal of Biological Chemistry, 1995
- Activation of the precursor of gelatinase A/72 kda type IV collagenase/MMP‐2 in lung carcinomas correlates with the expression of membrane‐type matrix metalloproteinase (MT‐MMP) and with lymph node metastasisInternational Journal of Cancer, 1995
- The C-terminal Region of Membrane Type Matrix Metalloproteinase Is a Functional Transmembrane Domain Required for Pro-gelatinase A ActivationJournal of Biological Chemistry, 1995
- A matrix metalloproteinase expressed on the surface of invasive tumour cellsNature, 1994